MedTrace Logo

Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing Data

NCT04792437 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-03-24

No results posted yet for this study

Summary

This project intends to use multiple types of biological samples from glioma patients and mouse intracranial tumor models as research objects, and comprehensively apply a series of omics sequencing technologies and molecular biology technologies to jointly define the following research objectives :

Conditions

  • Transcriptomics
  • Radiomics
  • Glioma

Interventions

PROCEDURE

surgery

surgery

Sponsors & Collaborators

  • Yu Yao, MD

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-10
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04792437 on ClinicalTrials.gov